Latest News

HRQOL, Not Outcomes, Differ Between United States and Chile in Osteosarcoma

HRQOL, Not Outcomes, Differ Between United States and Chile in Osteosarcoma

Study results indicate that although there are significant differences in HRQOL between the United States and Chile, clinical outcomes were similar.

Simpler 6-MP Administration in ALL May Improve Adherence

Simpler 6-MP Administration in ALL May Improve Adherence

Administration restrictions on oral mercaptopurine (6-MP) are unnecessary and may impair adherence among children with ALL.

Avelumab Receives Accelerated Approval for Merkel Cell Carcinoma

Avelumab Receives Accelerated Approval for Merkel Cell Carcinoma

The FDA granted accelerated approval to avelumab for the treatment of patients 12 years and older with Merkel cell carcinoma.

Mutation Analyses and Outcomes With GISTs

Mutation Analyses and Outcomes With GISTs

Data suggest that patients whose GIST harbors a KIT exon 11 deletion should receive imatinib for 3 years.

NCCN Launches Radiation Therapy Compendium

NCCN Launches Radiation Therapy Compendium

The NCCN is launching is a radiation therapy compendium to guide decision-making for patients receiving radiotherapy.

Gaps Remain in Skin Cancer Control Research

Gaps Remain in Skin Cancer Control Research

A study identified gaps in behavioral research, including interventions for targets, use of technology, theory, and environmental manipulation to improve intervention.

Low Uptake of BRCA Testing in High-risk Women

Low Uptake of BRCA Testing in High-risk Women

Study authors attributed some of the increase in testing among low-risk women to lack of knowledge of health care providers regarding the indication of the test.

Mid-NAC Ultrasound May Predict Response in Breast Cancer

Mid-NAC Ultrasound May Predict Response in Breast Cancer

Ultrasound findings at mid-NAC were associated with RCB among patients with TNBC and (HR)-negative, HER2-positive disease.

Radiotherapy Benefits Outweigh Risks in Breast Cancer

Radiotherapy Benefits Outweigh Risks in Breast Cancer

For most patients with breast cancer, the benefits of modern radiotherapy outweigh the risks of future secondary malignancy and heart disease.

Racial Disparities Persist in Treatment and Outcomes of Early Stage NSCLC

Racial Disparities Persist in Treatment and Outcomes of Early Stage NSCLC

Racial disparities in treatment and outcomes persist among patients diagnosed with NSCLC in spite of advances in curative therapies.

SBRT for Elderly Patients With Unresectable Lung Cancer

SBRT for Elderly Patients With Unresectable Lung Cancer

SBRT may be an effective strategy for elderly patients with unresectable lung cancer.

Reirradiation of Thoracic Cancers Provides Disease Control and Minimal Toxicity

Reirradiation of Thoracic Cancers Provides Disease Control and Minimal Toxicity

Definitive reirradiation of thoracic cancers with IMPT can provide durable local control with minimal toxicity and can extend survival.

ASCO Publishes Cervical Cancer Prevention Guideline

ASCO Publishes Cervical Cancer Prevention Guideline

ASCO published global recommendations for the primary prevention of cervical cancer in the Journal of Global Oncology.

Circulating Tumor Cell Monitoring Offers Early Prediction of Recurrent NSCLC

Circulating Tumor Cell Monitoring Offers Early Prediction of Recurrent NSCLC

Post-radiotherapy samples in 20 of 22 recurrences revealed that 15 of these patients (75%) had an increase in CTC counts.

Combining Radiotherapy and Immunotherapy: Adverse Events in Lung Cancer

Combining Radiotherapy and Immunotherapy: Adverse Events in Lung Cancer

In an analysis of metastatic lung cancer treated with thoracic radiotherapy and immunotherapy, 3 patients had severe toxicity.

Genetic Variations and Therapy Resistance in EGFR-mutant NSCLC

Genetic Variations and Therapy Resistance in EGFR-mutant NSCLC

Resistance to EGFR-targeted therapies may not be permanent; a single biopsy is insufficient for fully understanding the nature of therapy resistance.

Breast Cancer Subtype and Brain Metastasis Risk at Diagnosis

Breast Cancer Subtype and Brain Metastasis Risk at Diagnosis

Breast cancer subtype influences the probability that a patient has brain metastases at the time of diagnosis.

Improvement Needed in CML BCR-ABL1 Monitoring

Improvement Needed in CML BCR-ABL1 Monitoring

Technical standardization and development of the International Scale for reporting Philadelphia chromosome BCR-ABL1 fusion gene expression has improved consistency.

Phase 1b/2 Trial of Azacitidine, Durvalumab, and Tremelimumab for Head and Neck Cancer

Phase 1b/2 Trial of Azacitidine, Durvalumab, and Tremelimumab for Head and Neck Cancer

Researchers are evaluating an azacitidine, durvalumab, and tremelimumab combination for the treatment of head and neck cancer.

Couples Skill-training Trial in Head and Neck Cancer

Couples Skill-training Trial in Head and Neck Cancer

Researchers are evaluating a home-delivered coping and management strategy system for couples in which one partner has head and neck cancer.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters